LSE - Delayed Quote GBp

Hikma Pharmaceuticals PLC (HIK.L)

1,913.00 +59.00 (+3.18%)
At close: April 26 at 4:39 PM GMT+1
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for HIK.L

Recent News: HIK.L

View More
With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns

With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns
Simply Wall St. 12 days ago
Optimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past week

Optimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past week
Simply Wall St. last month

Merck's Bridion faces generic threat from drugmaker Hikma
Reuters last month
Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility

Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility
PR Newswire 2 months ago

High-dose opioid reversal spray no better than lower dose in field, US study finds
Reuters 2 months ago
Hikma announces US launch of COMBOGESIC® IV

Hikma announces US launch of COMBOGESIC® IV
PR Newswire 2 months ago

UPDATE 1-Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 million
Reuters 2 months ago
Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 million

Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 million
Reuters 2 months ago
Hikma Pharmaceuticals PLC's (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Hikma Pharmaceuticals PLC's (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Simply Wall St. 2 months ago
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa

Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
Business Wire 3 months ago
Are Investors Undervaluing Hikma Pharmaceuticals PLC (LON:HIK) By 26%?

Are Investors Undervaluing Hikma Pharmaceuticals PLC (LON:HIK) By 26%?
Simply Wall St. 4 months ago
Hikma Pharmaceuticals PLC's (LON:HIK) institutional investors lost 5.8% over the past week but have profited from longer-term gains

Hikma Pharmaceuticals PLC's (LON:HIK) institutional investors lost 5.8% over the past week but have profited from longer-term gains
Simply Wall St. 5 months ago
View More

Related Tickers

INDV.L Indivior PLC
1,408.00
+0.57%
 
HLN.L Haleon plc
334.40
+0.87%
 
EAH.L ECO Animal Health Group plc
107.50
+4.88%
 
U5Z.F Vertical Peak Holdings Inc.
0.0005
0.00%
 
VIVXF Avivagen Inc.
0.0064
0.00%
 
MGCLF Argent BioPharma Limited
0.2800
+9.37%
 
AUROPHARMA.BO Aurobindo Pharma Limited
1,131.15
+2.50%
 
BIOG-B.ST BioGaia AB (publ)
115.20
+1.23%
 
ALM.MC Almirall, S.A.
8.57
+1.24%
 
SIDO.JK PT Industri Jamu dan Farmasi Sido Muncul Tbk
705.00
-2.76%